MLSC, COBTH, UMass Med launch web portal to promote collaboration
The Massachusetts Life Sciences Center (MLSC) partnered with the Conference of Boston Teaching Hospitals (COBTH) and the University of Massachusetts Memorial Medical Center to the launch the Massachusetts Clinical Innovation Gateway. The new web portal will allow life sciences companies from around the world to seek opportunities to partner with Massachusetts academic medical centers (AMCs) on research and clinical initiatives.
The MLSC and COBTH have developed a form and process to triage partnership requests from interested life sciences companies. Companies seeking to explore partnership opportunities with Massachusetts AMC’s can complete the online form, which will be sent to representatives from each of the AMCs for review and consideration.
Participating AMCs include:
- Beth Israel Deaconess Medical Center
- Boston Children's Hospital
- Boston Medical Center
- Brigham and Women's Faulkner Hospital
- Brigham and Women's Hospital
- Cambridge Health Alliance
- Carney Hospital
- Dana-Farber Cancer Institute
- Floating Hospital for Children at Tufts Medical Center
- Lahey Hospital and Medical Center
- Massachusetts Eye and Ear
- Massachusetts General Hospital
- St. Elizabeth's Medical Center
- Tufts Medical Center
- UMass Memorial Medical Center
- VA Boston Healthcare
“This new tool will enable medical breakthroughs by offering companies in Massachusetts and throughout the world the opportunity to collaborate on product development and clinical studies with Massachusetts’ world-renowned research hospitals,” said Pamela Norton, MLSC vice president for Industry Relations and Programs. “We are excited about the collaborations that will result, the improvements in patient care that will follow, and the role that this new system will play in attracting even more global companies to the Massachusetts life sciences ecosystem.”
Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences ecosystem. Through nearly $600 million in public investment, which has leveraged more than $1.7 billion in third-party investment, Massachusetts has emerged as the global leader in life sciences, and as a magnet for companies large and small from all over the world.